Stock 4728 SUNMAX BIOTECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Sunmax Biotechnology Co., Ltd.

Equities

4728

TW0004728001

Biotechnology & Medical Research

End-of-day quote Taipei Exchange
Other stock markets
 18:00:00 2024-05-14 EDT 		5-day change 1st Jan Change
240 TWD -1.03% Intraday chart for Sunmax Biotechnology Co., Ltd. +4.12% +17.65%
03-15 Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 2,582 4,368 4,384 4,499 7,407 11,110
Enterprise Value (EV) 1 2,079 3,757 3,605 3,918 6,653 10,318
P/E ratio 34.4 x 43.6 x 18.4 x 18.3 x 13.9 x 17.8 x
Yield 2.53% 1.87% 2.48% 5.33% 6.99% -
Capitalization / Revenue 8.49 x 7.35 x 5.12 x 4.34 x 5.29 x 6.58 x
EV / Revenue 6.84 x 6.32 x 4.21 x 3.78 x 4.75 x 6.11 x
EV / EBITDA 29.8 x 20.6 x 10.4 x 9.86 x 8.31 x 11 x
EV / FCF 33.3 x 13.2 x 23.6 x 507 x 16.1 x 16.9 x
FCF Yield 3% 7.58% 4.24% 0.2% 6.2% 5.93%
Price to Book 3.98 x 6.45 x 4.93 x 4.4 x 5.59 x 7.79 x
Nbr of stocks (in thousands) 54,463 54,463 54,463 54,463 54,463 54,463
Reference price 2 47.40 80.20 80.50 82.60 136.0 204.0
Announcement Date 19-03-25 20-03-30 21-03-31 22-03-31 23-03-31 24-03-15
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 304.1 594.1 855.9 1,036 1,400 1,689
EBITDA 1 69.77 182.2 345.9 397.3 800.7 936.5
EBIT 1 62.8 175.1 332.3 367.4 768 894.8
Operating Margin 20.65% 29.46% 38.83% 35.47% 54.85% 52.98%
Earnings before Tax (EBT) 1 87.38 154.4 337.8 357.5 777.2 909.4
Net income 1 74.66 100.4 238.1 245.6 533.8 625.7
Net margin 24.55% 16.91% 27.82% 23.72% 38.13% 37.05%
EPS 2 1.376 1.840 4.370 4.510 9.790 11.47
Free Cash Flow 1 62.36 284.6 152.8 7.729 412.5 612.1
FCF margin 20.51% 47.9% 17.85% 0.75% 29.46% 36.24%
FCF Conversion (EBITDA) 89.38% 156.21% 44.18% 1.95% 51.52% 65.36%
FCF Conversion (Net income) 83.53% 283.34% 64.18% 3.15% 77.28% 97.82%
Dividend per Share 2 1.200 1.500 2.000 4.400 9.500 -
Announcement Date 19-03-25 20-03-30 21-03-31 22-03-31 23-03-31 24-03-15
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 502 611 780 580 754 793
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 62.4 285 153 7.73 413 612
ROE (net income / shareholders' equity) 12.2% 15.2% 30.4% 25.7% 45.5% 45.5%
ROA (Net income/ Total Assets) 5.53% 11.7% 16.8% 16.1% 29.3% 28.3%
Assets 1 1,349 858.7 1,420 1,524 1,822 2,211
Book Value Per Share 2 11.90 12.40 16.30 18.80 24.30 26.20
Cash Flow per Share 2 5.770 10.70 14.30 11.10 10.80 15.70
Capex 1 4.72 13.7 130 253 155 108
Capex / Sales 1.55% 2.3% 15.17% 24.43% 11.04% 6.37%
Announcement Date 19-03-25 20-03-30 21-03-31 22-03-31 23-03-31 24-03-15
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
SUNMAX BIOTECHNOLOGY CO., LTD. Stock Sunmax Biotechnology Co., Ltd.
+17.65% 408M
MODERNA, INC. Stock Moderna, Inc.
+29.32% 49.18B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+0.99% 42.11B
LONZA GROUP AG Stock Lonza Group AG
+50.47% 40.37B
CELLTRION, INC. Stock Celltrion, Inc.
-5.26% 28.85B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+13.64% 26.09B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-22.72% 18.71B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+8.42% 13.26B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+32.20% 12.32B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-0.74% 11.99B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. 4728 Stock
  4. Financials Sunmax Biotechnology Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW